David Renzi - Net Worth and Insider Trading

David Renzi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Renzi owns 2 companies in total, including KalVista Pharmaceuticals Inc (KALV) , and Minerva Surgical Inc (UTRS) .

Click here to see the complete history of David Renzi’s form 4 insider trades.

Insider Ownership Summary of David Renzi

Ticker	Company	Transaction Date	Type of Owner
KALV	KalVista Pharmaceuticals Inc	2015-08-03	director & President & CEO
UTRS	Minerva Surgical Inc	2021-10-21	director

David Renzi Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Renzi Ownership Network

Ownership Network List of David Renzi

No Data

Ownership Network Relation of David Renzi

David Renzi Owned Company Details

What does KalVista Pharmaceuticals Inc do?

Who are the key executives at KalVista Pharmaceuticals Inc?

David Renzi is the director & President & CEO of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include 10 percent owner Venrock Healthcare Capital Partners Iii, L.p. , CFO and Secretary Benjamin L Palleiko , and Chief Medical Officer Paul K. Audhya .

KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary

Over the past 18 months, David Renzi made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,612,229 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 161,456 shares made by Benjamin L Palleiko , and a net sale of 93,354 shares made by Christopher Yea .

In summary, during the past 3 months, insiders sold 21,811 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 361,212 shares, with a net purchase of 339,401 shares. During the past 18 months, 563,712 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,612,229 shares were bought by its insiders, resulting in a net purchase of 1,048,517 shares.

KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.

KalVista Pharmaceuticals Inc Insider Transactions

No Available Data

David Renzi Mailing Address

Above is the net worth, insider trading, and ownership report for David Renzi. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David Renzi's mailing address is: Palo Alto Ca 94304.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.